In-vivo dosimetric analysis in total skin electron beam therapy

Background and purpose: Thermoluminescent dosimetry (TLD) is an important element of total skin electron beam therapy (TSEBT). In this study, we compare radiation dose distributions to provide data for dose variation across anatomic sites. Materials and methods: Retrospectively collected data on 85...

Full description

Bibliographic Details
Main Authors: Khaled Elsayad, Christos Moustakis, Manuela Simonsen, Dagmar Bäcker, Uwe Haverkamp, Hans Theodor Eich
Format: Article
Language:English
Published: Elsevier 2018-04-01
Series:Physics and Imaging in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631617300829
id doaj-b973fe88a7b34560abf04549f526d608
record_format Article
spelling doaj-b973fe88a7b34560abf04549f526d6082020-11-24T23:41:30ZengElsevierPhysics and Imaging in Radiation Oncology2405-63162018-04-0166165In-vivo dosimetric analysis in total skin electron beam therapyKhaled Elsayad0Christos Moustakis1Manuela Simonsen2Dagmar Bäcker3Uwe Haverkamp4Hans Theodor Eich5Corresponding author at: Department of Radiation Oncology, University Hospital of Münster, Building A1, 1 Albert Schweitzer Campus, 48149 Münster, Germany.; Department of Radiation Oncology, University Hospital of Münster, Münster, GermanyDepartment of Radiation Oncology, University Hospital of Münster, Münster, GermanyDepartment of Radiation Oncology, University Hospital of Münster, Münster, GermanyDepartment of Radiation Oncology, University Hospital of Münster, Münster, GermanyDepartment of Radiation Oncology, University Hospital of Münster, Münster, GermanyDepartment of Radiation Oncology, University Hospital of Münster, Münster, GermanyBackground and purpose: Thermoluminescent dosimetry (TLD) is an important element of total skin electron beam therapy (TSEBT). In this study, we compare radiation dose distributions to provide data for dose variation across anatomic sites. Materials and methods: Retrospectively collected data on 85 patients with cutaneous lymphoma or leukemia underwent TSEBT were reviewed. Patients were irradiated on two linear accelerators, in one of two positions (standing, n = 77; reclined, n = 8) and 1830 in vivo TLD measurements were obtained for various locations on 76 patients. Results: The TLD results showed that the two TSEBT techniques were dosimetrically heterogeneous. At several sites, the dose administered correlated with height, weight, and gender. After the first TLD measurement, fourteen patients (18%) required MU modification, with a mean 10% reduction (range, −25 to +35). Individual TLD results allowed us to customize the boost treatment for each patient. For patients who were evaluated in the standing position, the most common underdosed sites were the axilla, perineum/perianal folds, and soles (each receiving 69%, 20%, and 34% of the prescribed dose, respectively). For patients evaluated in a reclining position, surface dose distribution was more heterogeneous. The sites underdosed most commonly were the axilla and perineum/perianal folds (receiving less than one third of prescribed dose). Significant variables were detected with model building. Conclusion: TLD measurements were integral to quality assurance for TSEBT. Dose distribution at several anatomical sites correlated significantly with gender, height, and weight of the treated individual and might be predicted. Keywords: Dosimeter, Cutaneous lymphoma, Leukemia cutis, Mycosis fungoides, Dose distribution, Total skin electron beamhttp://www.sciencedirect.com/science/article/pii/S2405631617300829
collection DOAJ
language English
format Article
sources DOAJ
author Khaled Elsayad
Christos Moustakis
Manuela Simonsen
Dagmar Bäcker
Uwe Haverkamp
Hans Theodor Eich
spellingShingle Khaled Elsayad
Christos Moustakis
Manuela Simonsen
Dagmar Bäcker
Uwe Haverkamp
Hans Theodor Eich
In-vivo dosimetric analysis in total skin electron beam therapy
Physics and Imaging in Radiation Oncology
author_facet Khaled Elsayad
Christos Moustakis
Manuela Simonsen
Dagmar Bäcker
Uwe Haverkamp
Hans Theodor Eich
author_sort Khaled Elsayad
title In-vivo dosimetric analysis in total skin electron beam therapy
title_short In-vivo dosimetric analysis in total skin electron beam therapy
title_full In-vivo dosimetric analysis in total skin electron beam therapy
title_fullStr In-vivo dosimetric analysis in total skin electron beam therapy
title_full_unstemmed In-vivo dosimetric analysis in total skin electron beam therapy
title_sort in-vivo dosimetric analysis in total skin electron beam therapy
publisher Elsevier
series Physics and Imaging in Radiation Oncology
issn 2405-6316
publishDate 2018-04-01
description Background and purpose: Thermoluminescent dosimetry (TLD) is an important element of total skin electron beam therapy (TSEBT). In this study, we compare radiation dose distributions to provide data for dose variation across anatomic sites. Materials and methods: Retrospectively collected data on 85 patients with cutaneous lymphoma or leukemia underwent TSEBT were reviewed. Patients were irradiated on two linear accelerators, in one of two positions (standing, n = 77; reclined, n = 8) and 1830 in vivo TLD measurements were obtained for various locations on 76 patients. Results: The TLD results showed that the two TSEBT techniques were dosimetrically heterogeneous. At several sites, the dose administered correlated with height, weight, and gender. After the first TLD measurement, fourteen patients (18%) required MU modification, with a mean 10% reduction (range, −25 to +35). Individual TLD results allowed us to customize the boost treatment for each patient. For patients who were evaluated in the standing position, the most common underdosed sites were the axilla, perineum/perianal folds, and soles (each receiving 69%, 20%, and 34% of the prescribed dose, respectively). For patients evaluated in a reclining position, surface dose distribution was more heterogeneous. The sites underdosed most commonly were the axilla and perineum/perianal folds (receiving less than one third of prescribed dose). Significant variables were detected with model building. Conclusion: TLD measurements were integral to quality assurance for TSEBT. Dose distribution at several anatomical sites correlated significantly with gender, height, and weight of the treated individual and might be predicted. Keywords: Dosimeter, Cutaneous lymphoma, Leukemia cutis, Mycosis fungoides, Dose distribution, Total skin electron beam
url http://www.sciencedirect.com/science/article/pii/S2405631617300829
work_keys_str_mv AT khaledelsayad invivodosimetricanalysisintotalskinelectronbeamtherapy
AT christosmoustakis invivodosimetricanalysisintotalskinelectronbeamtherapy
AT manuelasimonsen invivodosimetricanalysisintotalskinelectronbeamtherapy
AT dagmarbacker invivodosimetricanalysisintotalskinelectronbeamtherapy
AT uwehaverkamp invivodosimetricanalysisintotalskinelectronbeamtherapy
AT hanstheodoreich invivodosimetricanalysisintotalskinelectronbeamtherapy
_version_ 1725507003405565952